What is the Ethics in Prevention training?
This Ethics in Prevention training is designed to help participants understand and apply ethical principles in the field of substance misuse prevention, particularly in prevention efforts focused on opioid and stimulant use. Using case examples and interactive activities, participants will explore the six standards in the Prevention Code of Ethics and learn to use a four-step decision-making process to assess, address, and evaluate a range of ethical issues.
By the end of this training, participants will have:
- Defined ethics and related terms
- Described the six principles in the Prevention Code of Ethics
- Practiced using an ethical decision-making process to apply the Prevention Code of Ethics
This training is relevant to those seeking certification or recertification as a Prevention Specialist and meets the basic requirements for prevention ethics for this type of certification. This training will not meet the requirements for anyone seeking treatment or recovery support-related certification or licensure.
Are continuing education hours available?
- The IC&RC Prevention Committee has endorsed the new Ethics in Prevention training as an IC&RC-approved curriculum. This endorsement provides assurance that this course is applicable to IC&RC’s Prevention Code of Ethics and can be used toward the education/training requirement for IC&RC’s Prevention Specialist credential.
- Participants completing the training will receive a certificate for seven (7) hours of participation. They can submit these certificates to their credentialing authority toward certification or re-certification.
Date and Time
Tuesday, February 24, 2026
8:30-5:00 pm
Location:
NyE Communities Coalition Campus
1020 E Wilson Rd
Pahrump, NV 89048
Room #31 and #32
Training Facilitator
Christina Lopez-Guiterrez
Who Should Participate
Community, tribal, jurisdiction, and state-level substance misuse prevention practitioners and allied health partners located in Nevada.
Funding for this training was made possible in whole or in part by the Nevada Department of Health and Human Services (DHHS) Director’s Office through the Fund for a Resilient Nevada, established in Nevada Revised Statutes 433.712 through 433.744, and by Washoe County through the One Nevada Agreement allocation of the Washoe Opioid Abatement and Recovery Fund (Grant #WOARF24-00003). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Nevada Opioid Center of Excellence, DHHS, or Washoe County.
